Dermatology Times, July 2021 (Vol. 42, No. 7)

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explores the world of eyebrows, including microblading, grooming, and shape.

In this month's Legal Eagle column, David J. Goldberg, MD, JD, explores chat room referrals and how they could possibly alter the physician-patient relationship.

New and forthcoming options bring opportunity for optimizing patient care.

Dermoscopy cannot diagnose D folliculorum proliferation but can reveal specific findings in patients with papulopustular rosacea.

Combined, these efforts encourage active participation in the care process and drive sustained behavior change.

Hair regrowth was observed after starting dupilumab treatment in some pediatric patients with a history of severe and refractory alopecia areata (AA) and concomitant atopic dermatitis (AD).

Dermatologists are expanding their skill sets and exploring new techniques to enable gender-diverse patients to achieve their medical and aesthetic goals.

Creating an effective treatment regimen for adult females with acne requires a holistic approach that considers the physical and psychological aspects of the world’s most common skin condition.

The Journal of the American Academy of Dermatology has published new recommendations for the treatment of actinic keratosis (AK).

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of June.

Secukinumab (Cosentyx, Novartis) has received FDA approval for the treatment of children and adolescents with moderate to severe plaque psoriasis.

Ruxolitinib cream (Jakafi, Incyte) demonstrated positive results in 2 phase 3 studies investigating the topical for treatment of vitiligo in patients 12 years and older